scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1047395592 |
P356 | DOI | 10.1186/1471-2458-11-899 |
P932 | PMC publication ID | 3262832 |
P698 | PubMed publication ID | 22129083 |
P5875 | ResearchGate publication ID | 51841765 |
P50 | author | Manuel García Cenoz | Q42893858 |
F Pozo | Q55069602 | ||
Nuria Torner | Q56374331 | ||
Silvia Jiménez-Jorge | Q56486868 | ||
Jone M Altzibar | Q57080059 | ||
Inmaculada Casas | Q41274828 | ||
Amparo Larrauri | Q41928148 | ||
P2093 | author name string | Ana Martinez | |
Camelia Savulescu | |||
Jesús Castilla | |||
Carmen Quiñones | |||
Carolina Rodriguez | |||
Salvador de Mateo | |||
Maria C Serrano | |||
Milagros Perucha | |||
Tomas Vega | |||
Pilar Pérez Breña | |||
Julián M Ramos | |||
Jose M Arteagoitia | |||
Antonia Galmés | |||
Juana M Vanrell | |||
P2860 | cites work | New influenza A(H1N1) virus infections in Spain, April-May 2009. | Q44366595 |
Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network--pilot case-control studies using different control groups, 2008-2009 season, Spain | Q45792636 | ||
Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season | Q46159620 | ||
Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. | Q48071872 | ||
Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks | Q50129178 | ||
Characterisation of swabbing for virological analysis in the Spanish Influenza Sentinel Surveillance System during four influenza seasons in the period 2002-2006 | Q59637012 | ||
Low Pathogenicity Avian Influenzas and human health | Q81295942 | ||
Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study | Q21144621 | ||
Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. | Q30357784 | ||
First steps in the design of a system to monitor vaccine effectiveness during seasonal and pandemic influenza in EU/EEA Member States. | Q30372912 | ||
Estimating influenza vaccine effectiveness using routinely collected laboratory data. | Q30382480 | ||
Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010. | Q30389024 | ||
Vaccine effectiveness in pandemic influenza - primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine. | Q30391398 | ||
Effectiveness of seasonal 2008–2009, 2009–2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case–control study | Q30394200 | ||
Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. | Q30398764 | ||
Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. | Q30399334 | ||
Influenza pandemic (H1N1) 2009 activity during summer 2009. Effectiveness of the 2008-9 trivalent vaccine against pandemic influenza in Spain | Q30399902 | ||
Betulin is a potent anti-tumor agent that is enhanced by cholesterol | Q30862438 | ||
Estimation of influenza vaccine effectiveness from routine surveillance data | Q33424462 | ||
European Influenza Surveillance Scheme on the Internet. | Q38549453 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | pandemic | Q12184 |
periodic health examination | Q1762591 | ||
P304 | page(s) | 899 | |
P577 | publication date | 2011-11-30 | |
P1433 | published in | BMC Public Health | Q15767009 |
P1476 | title | Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010. | |
P478 | volume | 11 |
Q34707079 | Effectiveness of MF59™ adjuvanted influenza A(H1N1)pdm09 vaccine in risk groups in the Netherlands |
Q34993133 | Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination |
Q30367263 | Effectiveness of pandemic and seasonal influenza vaccines in preventing laboratory-confirmed influenza in adults: a clinical cohort study during epidemic seasons 2009-2010 and 2010-2011 in Finland. |
Q30419179 | Effectiveness of pandemic and seasonal influenza vaccines in preventing pandemic influenza-associated hospitalization |
Q30414952 | Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study |
Q30833500 | Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011. |
Q42148972 | Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the seasons 2010-2014. |
Q30426753 | Neonatal outcomes after antenatal influenza immunization during the 2009 H1N1 influenza pandemic: impact on preterm birth, birth weight, and small for gestational age birth |
Q34778408 | Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review |
Q30361429 | Protective effects of influenza A (H1N1) pandemic 2009 vaccination against the onset of influenza-like illness and asthma exacerbation in Japanese children. |
Q90692852 | The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology |
Q38803189 | Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies |
Q39884379 | Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15. |
Search more.